Search

everythinglearnresearchcommunity

for

Search:↓

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

No link found between new male baldness genes and female hair loss.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Prolactin affects when mice shed and grow hair.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Finasteride affects young male rats' brain function and behavior negatively.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Various treatments exist for hair loss, but more research is needed for better options.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.